AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy

There is growing epidemiological evidence indicating an association between diabetes mellitus and the increased incidence of colorectal cancer (CRC). The preferred initial and most widely used pharmacological agent for the treatment of type 2 diabetes is metformin, which in parallel reduces the risk...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Martisova, Andrea, Sommerova, Lucia, Kuricova, Katarina, Podhorec, Jan, Vojtesek, Borivoj, Kankova, Katerina, Hrstka, Roman
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2019
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781747/
https://ncbi.nlm.nih.gov/pubmed/31612008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10800
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi